LiveRamp Prices Neutrality Risk, Not Cash

Summary: RAMP.US closed at $37.70 on a Stooq quote feed timestamped 2026-05-22 22:00:24 UTC, leaving the stock $0.80 or about 2.1% below Publicis' signed $38.50 all-cash merger price announced on May 17, 2026. The merger agreement already includes unanimous board approval, a reciprocal $32.35 million termination fee, a stated outside date of May 16, 2027 with a three-month regulatory extension, and explicit coverage of HSR, non-U.S. antitrust, foreign direct investment, and CFIUS approvals. On the same day, LiveRamp printed a strong fiscal 2026 finish: 9% revenue growth, 22% non-GAAP operating margin, $168 million of operating cash flow, 107% subscription net retention, and $379.5 million of cash, cash equivalents, and restricted cash at year-end. The market is still charging a neutrality and regulatory discount to a signed cash exit even though the target is not a broken asset and the contract already names the risk. [1][2][3][4]

Opportunity Ranking

Rank	Idea	Discovery Lane	Why It May Be Best Now	Evidence Freshness	Catalyst Window	Asymmetry	Main Reason to Reject
1	LiveRamp prices neutrality risk, not cash	U.S. / software / signed strategic merger	The stock closed at $37.70 against a signed $38.50 cash deal announced only May 17, while the target also reported strong operating cash flow, high retention, and a large net-cash position the same day. [1][2][3][4]	Very high. Live quote checked this run; merger announcement and 8-K are dated May 17-18, 2026; fiscal 2026 results are dated May 17, 2026. [1][2][3][4]	Proxy filing, HSR and other regulatory work, then expected close before year-end 2026. [2][3]	Best mix of freshness, monitorability, and spread size in the U.S. screen.	Selected.
2	KalVista spread still leaves a little money on the table	U.S. / biotech / board-backed cash tender	`KALV.US` closed at $26.79 against a signed $27.00 cash tender from Chiesi. The bid is board-backed and explicitly has no financing condition. [5][6]	High. Live quote checked this run; official transaction release dated April 29, 2026. [5][6]	Tender path through Q3 2026. [5]	Defined outcome, but only about 0.8% gross spread.	Too thin for the best slot.
3	Amex GBT trades like a locked vote is the same as cash in hand	U.S. / travel software / signed cash merger	`GBTG.US` closed at $9.44 against a $9.50 cash deal, with holders representing 69% already committed to vote for the merger. [7][8]	High. Live quote checked this run; official merger announcement dated May 4, 2026. [7][8]	Shareholder vote and regulatory work for a stated second half of 2026 close. [7]	Clean but thin.	The spread is smaller than LiveRamp's and the time to close is longer.

Selected opportunity: LiveRamp Holdings (RAMP.US).

Why this one now: It is the freshest U.S. signed-cash deal in the screen with the widest clean spread and the best standalone downside support.

What should surprise the reader: The market is still demanding a real discount to a signed cash exit even though the contract already prices the regulatory path and the target reported a high-quality, cash-generative finish the same day the deal was announced.

Scope Note

This run was explicitly constrained by the user to the U.S. market only. I screened U.S. candidates only.

The Setup

Publicis is buying LiveRamp for $38.50 a share in cash. The announced equity value is $2.546 billion and the implied enterprise value is $2.167 billion, which means the buyer is acquiring a profitable data-collaboration platform with meaningful balance-sheet cash rather than rescuing a weak software asset. Publicis said the deal is expected to close before year-end 2026, subject to regulatory approvals, LiveRamp shareholder approval, and other customary conditions. [2]

The same morning, LiveRamp reported a clean fiscal year. Revenue rose 9% to $813 million, non-GAAP operating income reached $182 million, subscription net retention improved to 107%, and operating cash flow hit a record $168 million. Year-end cash, cash equivalents, and restricted cash stood at $379.5 million. [4]

The contract matters too. LiveRamp's May 18 8-K says the board approved the merger unanimously, the deal has a standard shareholder vote structure rather than a tender shortcut, the outside date is May 16, 2027 with a three-month automatic extension if only certain regulatory conditions remain, and either side owes $32.35 million in specified termination scenarios, including a parent-side fee if regulatory approvals fail by the outside date while the other conditions are otherwise satisfied. [3]

This is why the file is interesting. The market is not looking at a soft rumor or a buyer that can shrug and walk away for free.

The Mispricing

The market is still pricing neutrality risk more heavily than signed cash.

LiveRamp is a data-collaboration layer used across advertisers, publishers, and agencies. Publicis is one of the largest agency holding companies in the world. The obvious bear case is that a neutral utility becomes less neutral under agency ownership, clients get nervous, and regulators take a harder look.

That concern is real. It is not enough to explain the whole spread.

The variant view is narrower:

The key risks are already named in the merger agreement and the buyer accepted a reciprocal regulatory break fee. [3]
The target is fundamentally healthy, which limits how much standalone value should evaporate if the path gets noisy. [4]
At $37.70, the market still prices the deal as if neutrality anxiety is closer to a thesis-break than a known closing condition. [1][2][3]

This is not free money. It is a signed-cash situation where the market still pays you to warehouse a fear that is already in the documents.

Price

Market Level	Value	Timestamp / Source	Why It Matters
`RAMP` regular-session close	$37.70	Stooq feed timestamped 2026-05-22 22:00:24 UTC [1]	Current reference price.
Publicis cash consideration	$38.50	Official Publicis announcement dated May 17, 2026 and LiveRamp 8-K filed May 18, 2026 [2][3]	Hard cash benchmark.
Gross spread to cash	2.1%	Calculated from current close and merger price [1][2]	The market still demands compensation to hold the deal.
Equity value	$2.546 billion	Publicis announcement [2]	Confirms buyer size and commitment.
Enterprise value	$2.167 billion	Publicis announcement [2]	Shows the buyer is effectively paying for the operating asset net of cash.
Year-end cash, cash equivalents and restricted cash	$379.5 million	LiveRamp fiscal 2026 results [4]	Important for downside framing.
FY2026 operating cash flow	$168 million	LiveRamp fiscal 2026 results [4]	Standalone quality matters if the deal wobbles.
Subscription net retention	107%	LiveRamp fiscal 2026 results [4]	Evidence that the asset was not deteriorating into the deal.
Reciprocal termination fee	$32.35 million	LiveRamp 8-K [3]	Regulatory risk is not costless for the buyer.
Outside date	May 16, 2027	LiveRamp 8-K [3]	Sets the real time-risk ceiling.

The disagreement is simple. The market sees a signed $38.50 exit and still prices the stock at $37.70.

Positioning

I do not have a verified live map of merger-arb ownership, short interest, stock-loan pricing, or options skew for RAMP.US in this run. That is a real limitation and lowers confidence.

What is verified:

The stock was already expensive enough on a standalone basis that Publicis had to pay a 29.8% premium to the May 15 close to win the asset. [2]
The board approved the deal unanimously. [3]
The business entered the merger from a position of operating strength, not distress. [4]

The inference is that the market is not discounting a weak target. It is discounting client, neutrality, and regulatory friction. That is a different kind of spread. It is less about whether the seller wants the deal and more about whether the ecosystem tolerates the buyer.

Catalyst

The catalyst path is visible even if the exact dates are not all filed yet.

Proxy path: LiveRamp must file a merger proxy because this is a shareholder-vote deal rather than a tender offer. [3]
Regulatory path: The 8-K explicitly names HSR, non-U.S. antitrust, foreign direct investment approvals, and CFIUS as conditions. [3]
Client read-through: The market will watch whether major customers and partners treat Publicis ownership as manageable or corrosive. That is a softer catalyst, but it should surface through industry commentary and the absence or presence of public contract anxiety.
Time compression: If the proxy lands cleanly and there is no early evidence of customer flight, the spread should narrow before closing, not only at closing.

This is the closing mechanism. The market does not need to fall in love with Publicis. It only needs to get less afraid of a deal that is already signed.

Payoff Map

The cleanest expression is long RAMP.US common stock.

This is not an options-first setup. I did not safely verify a liquid options chain in this run, and the edge here comes from merger-spread compression against a known cash term, not from a volatility view.

The second-best expression is no trade until the first merger-proxy filing. That is safer. It also risks giving up most of a narrow spread if the first filing and early regulatory path look routine.

Price Target and Probability Map

Scenario	Probability	Target / Level	Return / Payoff	Time Horizon	Conditions Required	Evidence Quality
Top Case	15%	$39.25	+4.1%	1 to 5 months	A rival or process pressure forces a modest bump, or the spread collapses close to certainty faster than expected.	Low
Base Case	70%	$38.50	+2.1%	1 to 7 months	Proxy process stays clean, customer concerns do not metastasize, and the signed deal closes on current terms before year-end 2026.	High
Bottom Case	15%	$34.50	-8.5%	Immediate to 12 months	Regulatory or ecosystem friction widens materially, or the deal breaks and the stock falls back toward a standalone quality-software valuation rather than the full pre-deal level.	Medium
Invalidation / Stop Condition	n/a	Clear evidence that regulators or major customers are blocking the path, or a sustained break below $34 on adverse deal-specific news	Thesis broken	Immediate once visible	If neutrality risk becomes an actual closing failure rather than a priced fear, the spread thesis is over.	Medium

Probability-weighted expected value: $37.99, or about +0.8% versus the current $37.70. Current market price / level: RAMP.US $37.70 Timestamp: Stooq feed timestamped 2026-05-22 22:00:24 UTC Primary instrument: RAMP.US common stock Alternative expressions considered: Wait for the merger proxy; options only after separate live chain verification Confidence: Medium

What Would Prove This Wrong

This thesis fails if the market is right that LiveRamp's neutrality is too important to the ecosystem for Publicis ownership to clear smoothly.

The clean falsifiers are:

A regulatory process that drifts from routine review into explicit resistance.
Public evidence that major clients or data partners are preparing to cut exposure because agency ownership changes the platform's perceived neutrality.
A widening spread driven by deal-specific break signals rather than generic market weakness.

If that happens, this stops being a quality-target spread and becomes a broken-process story.

Risk Audit

Strongest counterargument: LiveRamp's value rests on being trusted by parties that do not want an agency gatekeeper in the middle. The market may be right that Publicis ownership creates a more serious ecosystem problem than ordinary merger-arb math admits.

Most fragile assumption: That LiveRamp's strong standalone operating quality will still matter if the buyer's ownership model itself becomes the problem.

What the market may already know: The contract already flags CFIUS, antitrust, and foreign direct investment approvals, which means the market is not inventing the regulatory risk.

What could make the trade lose money even if the thesis is directionally right: Delay. A clean close late in 2026 can still be a mediocre annualized result if the spread does not compress earlier.

Liquidity / execution risks: RAMP.US trades liquid enough for most equity execution, but deal spreads can gap wider on rumor or regulatory headlines.

Leverage risks: Poor fit. A narrow-spread, event-driven trade should not be levered aggressively.

Information reliability risks: I did not verify live stock-loan, options-chain, or merger-arb positioning data in this run.

Invalidation trigger: Clear adverse regulatory escalation, major customer defection tied to the buyer, or a sustained break below $34 on deal-specific news.

Publish / revise / reject recommendation: Publish.

Best Trade Strategy

Best trade: Long RAMP.US common stock.

This is not a short. It is not an options-first trade. The edge, if there is one, comes from the market still discounting a signed cash deal as though neutrality risk were unknowable, when in fact the contract and the target's balance sheet already make the risk more legible than the price implies.

Bottom Line

LiveRamp is not mispriced because Publicis is guaranteed to close the deal without friction.

It is mispriced because the market is still charging a full fear premium to a risk that is already named, bounded, and attached to a healthy target. The contract spells out the regulatory map. The board already approved the sale. The target printed record operating cash flow, strong retention, and nearly $380 million of year-end cash on the same day it agreed to sell. At $37.70, the stock still trades below a signed $38.50 cash exit because the market distrusts the ownership handoff more than the current documents justify. The trade is long RAMP.US common stock.

Research Quality Scorecard

Criterion	Score	Evidence note
Market disagreement	4	There is a clear disagreement between signed cash at $38.50 and a still-material market discount at $37.70, but the spread is narrower than a classic busted file.
Evidence base	5	Core claims come from a live quote feed, the official Publicis announcement, LiveRamp's 8-K, and same-day fiscal results.
Positioning and flows	2	The positioning inference is plausible, but verified arb-holder, borrow, and options-flow data are missing.
Catalyst path	4	The proxy, HSR, FDI, and CFIUS path are explicit, though the exact vote date is not yet public.
Payoff architecture	3	The spread is defined, but upside is modest and the trade relies on deal completion rather than explosive rerating.
Invalidation discipline	4	Deal-specific regulatory or customer-friction signals create a clear thesis break.
Differentiated insight	4	The key angle is that the market is pricing ownership-model fear more heavily than the contract and the target's standalone quality justify.
Client value	4	Even readers who do not take the trade get a clean framework for how to think about neutrality-risk merger spreads.

Total score: 30 / 40

Publish decision: Watchlist / Short Note

AI Illustration Prompt

Create a realistic, high-value, high-end elite editorial cover image for The Mispricing Desk about LiveRamp trading below a signed cash exit because the market still fears loss of neutrality under agency ownership. Show a refined institutional conference room after hours, with a polished charcoal table holding two objects in tension: a crisp ivory cash card stamped $38.50 CASH and a translucent identity-grid panel labeled subtly Neutrality that casts a faint shadow across the card. Behind them, place a secure data clean-room wall made of frosted glass and steel, with soft reflections of advertisers, publishers, and agencies standing apart but connected through thin light channels. Add a discreet ticker plaque reading RAMP 37.70, a contract tab marked CFIUS / HSR / FDI, and a restrained balance-sheet slip hinting at $379m cash and 107% retention. The visual metaphor is not growth versus decline. It is trust versus ownership. Mood: skeptical, elegant, forensic, expensive. Palette: graphite, paper white, muted teal, brushed steel, and a small amber accent. Style: Bloomberg Markets realism with The Economist discipline and Barron's restraint. No generic green charts, no handshakes, no AI slop. Include a subtle but clear watermark or text treatment reading The Mispricing Desk.